window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

immunology

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Phase 1 trial of novel HIV vaccine begins in Africa led by local researchers

    A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Pharvaris raises $175 million to advance oral therapy for hereditary angioedema

    Pharvaris has secured approximately $175 million through a public offering [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    QuantHealth clinical trial simulations deliver $31.4m savings and 90% accuracy

    QuantHealth has simulated more than 350 clinical trials using its [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    NICE backs mirikizumab for treatment-resistant Crohn’s disease

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 5, 2026
  • Drug Discovery & Development

    Glen Clova Scientific relocates R&D operations to support pipeline expansion

    Glen Clova Scientific has moved its R&D operations to the [...]

    May 5, 2026
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FORE Biotherapeutics completes enrolment in registrational plixorafenib brain tumour study
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Study quantifies financial benefits of risk-based quality management in oncology trials
    Categories: Clinical & Regulatory, Digital & Data, Research & Development
  • Compass reports second positive Phase 3 trial of psilocybin therapy for treatment-resistant depression
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top